RhumbLine Advisers’s 89bio ETNB Stock Holding History

RhumbLine Advisers’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-189,817	Closed	-$2.79M	–	4143
2025 Q3	$2.79M	Sell	189,817 -4,001	-2%	-$40.8K	﹤0.01%	1724
2025 Q2	$1.9M	Buy	193,818 +41,680	+27%	+$345K	﹤0.01%	1914
2025 Q1	$1.11M	Buy	152,138 +22,158	+17%	+$194K	﹤0.01%	2123
2024 Q4	$1.02M	Buy	129,980 +4,125	+3%	+$34K	﹤0.01%	2236
2024 Q3	$931K	Sell	125,855 -3,089	-2%	-$26K	﹤0.01%	2294
2024 Q2	$1.03M	Buy	128,944 +27,334	+27%	+$244K	﹤0.01%	2224
2024 Q1	$1.18M	Buy	101,610 +17,521	+21%	+$194K	﹤0.01%	2162
2023 Q4	$939K	Buy	84,089 +2,616	+3%	+$24K	﹤0.01%	2288
2023 Q3	$1.26M	Buy	81,473 +3,257	+4%	+$54.7K	﹤0.01%	2085
2023 Q2	$1.48M	Buy	+78,216	New	+$1.37M	﹤0.01%	2075
2022 Q2	–	Sell	-11,173	Closed	-$42K	–	3142
2022 Q1	$42K	Buy	+11,173	New	+$72K	﹤0.01%	2984

Other funds holding ETNB

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

RhumbLine Advisers's ETNB Position: Q4 2025 in Review

RhumbLine Advisers sold out of 89bio (ETNB) in Q4 2025, closing a stake of 189,817 shares — an estimated $2.79M sold.

RhumbLine Advisers first reported a position in ETNB in Q1 2022 and held it in 11 quarters. The position peaked at $2.79M in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

RhumbLine Advisers reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
RhumbLine Advisers sold 189,817 89bio shares in Q4 2025, an estimated $2.79M.
RhumbLine Advisers first reported a position in 89bio in Q1 2022 and held it in 11 quarters.
RhumbLine Advisers's 89bio position peaked at $2.79M in Q3 2025.
2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on RhumbLine Advisers's 13F filing for Q4 2025, filed 13 Feb 2026.